HRTX

NASDAQ · Biotechnology

Heron Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.26

+0.05 (+4.13%)

As of Feb 8, 2:03 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +1,710.3% upside

Low Target $15.42

Average Target $22.81

High Target $25.92

Current Price $1.26

Current
$1.26

Target
$22.81

$15.42 $22.81 avg $25.92

Scenario Analysis

Bear Case

$15.42

1,123.8%

Low target

Base Case

$22.81

+1,710.3%

Avg target

Bull Case

$25.92

+1,957.1%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$23.23

-94.6% from high

52-Week Low

$15.35

+-91.8% from low

Target vs 52W High

$22.81

-1.8% vs high

Next Earnings Report

Mar 4, 2026 · After Market Close

16d

until earnings

EPS Est: $-0.02

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%